Cargando…

The preventive cardiovascular effect of a combination of statin and angiotensin receptor blocker at sub-therapeutic doses in middle-aged healthy volunteers

Detalles Bibliográficos
Autores principales:	Šinigoj, Petra, Lunder, Mojca, Šinigoj, Martin, Drevenšek, Gorazd, Šabovič, Mišo
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778937/ http://dx.doi.org/10.1186/1471-2210-9-S2-A63

Ejemplares similares

A low-dose atorvastatin and losartan combination directly improves aortic ring relaxation and diminishes ischaemic-reperfusion injury in isolated rat hearts
por: Lunder, Mojca, et al.
Publicado: (2012)

Cardiotoxic activity of polymeric 3-alkylpyridinium salts from the marine sponge Reniera sarai
por: Lunder, Mojca, et al.
Publicado: (2009)

Arterial Stiffness and Cardiovascular Therapy
por: Janić, Miodrag, et al.
Publicado: (2014)

Cardioprotective effects of bilberry extract on ischemia-reperfusion-induced injury in isolated rat heart
por: Žiberna, Lovro, et al.
Publicado: (2009)

Presence of bilitranslocase in the vascular system and its role in the vasodilatation activity of anthocyanins
por: Žiberna, Lovro, et al.
Publicado: (2009)

Associations among different functional and structural arterial wall properties and their relations to traditional cardiovascular risk factors in healthy subjects: a cross-sectional study
por: Lunder, Mojca, et al.
Publicado: (2012)

Coenzyme Q10 Supplementation Decreases Statin-Related Mild-to-Moderate Muscle Symptoms: A Randomized Clinical Study
por: Skarlovnik, Ajda, et al.
Publicado: (2014)

A Low-Dose Combination of Fluvastatin and Valsartan: A New “Drug” and a New Approach for Decreasing the Arterial Age
por: Janić, Miodrag, et al.
Publicado: (2015)

Treating Arterial Ageing in Patients with Diabetes: From Mechanisms to Effective Drugs
por: Lunder, Mojca, et al.
Publicado: (2021)

Expression of Longevity Genes Induced by a Low-Dose Fluvastatin and Valsartan Combination with the Potential to Prevent/Treat “Aging-Related Disorders”
por: Janić, Miodrag, et al.
Publicado: (2019)

The Network for Evaluation of One Health: evidence-based added value of One Health
por: Haxton, Eva, et al.
Publicado: (2015)

Cardioprotective effects of silver fir (Abies alba) extract in ischemic-reperfused isolated rat hearts
por: Drevenšek, Gorazd, et al.
Publicado: (2016)

Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS)
por: Janić, Miodrag, et al.
Publicado: (2022)

Empagliflozin on top of metformin treatment improves arterial function in patients with type 1 diabetes mellitus
por: Lunder, Mojca, et al.
Publicado: (2018)

Endothelin-1 increases osteoclastic bone resorption via endothelin A receptors during orthodontic tooth movement in rats
por: Sprogar, Špela, et al.
Publicado: (2009)

The effect of cetirizine, an H(1 )receptor antagonist, on bone modeling during orthodontic tooth movement in rats
por: Meh, Alja, et al.
Publicado: (2009)

Cellular antioxidant activity of bilirubin in the human endothelial cell line EA.hy 926 is mediated by bilitranslocase
por: Žiberna, Lovro, et al.
Publicado: (2009)

Empagliflozin-Metformin Combination Has Antioxidative and Anti-Inflammatory Properties that Correlate with Vascular Protection in Adults with Type 1 Diabetes
por: Janić, Miodrag, et al.
Publicado: (2022)

Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?
por: Wiwanitkit, Viroj
Publicado: (2016)

Reply to “Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?”
por: Fedson, David S., et al.
Publicado: (2016)

Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor Blockers
por: Fedson, David S., et al.
Publicado: (2015)

Synergistic protective effects of a statin and an angiotensin receptor blocker for initiation and progression of atherosclerosis
por: Lee, Seul-Gee, et al.
Publicado: (2019)

Effect of Statins, Metformin, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers on Age-Related Macular Degeneration
por: Lee, Hyesung, et al.
Publicado: (2019)

Reappraisal of role of angiotensin receptor blockers in cardiovascular protection
por: Ram, C Venkata S
Publicado: (2011)

Effect of renin angiotensin blockers on angiotensin converting enzyme 2 level in cardiovascular patients
por: Farid fahmy, Sarah, et al.
Publicado: (2023)

EHMTI-0217. Neurophysiological study of tdcs effects in healthy volunteers
por: Baschi, R, et al.
Publicado: (2014)

No Evidence for Statin-induced Proteinuria in Healthy Volunteers as Assessed by Proteomic Analysis
por: Verhulst, Anja, et al.
Publicado: (2011)

Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?
por: Eroğlu, İmdat, et al.
Publicado: (2020)

A comparative study on the anti-inflammatory effect of angiotensin-receptor blockers & statins on rheumatoid arthritis disease activity
por: Mostafa, Tarek Mohamed, et al.
Publicado: (2020)

Volunteers
por: Briard, Francois
Publicado: (2019)

Lipoprotein(a) and inflammation in patients with atrial fibrillation after electrical cardioversion
por: Naji, Franjo, et al.
Publicado: (2011)

Inflammatory, Metabolic, and Coagulation Effects on Medial Arterial Calcification in Patients with Peripheral Arterial Disease
por: Nikolajević, Jovana, et al.
Publicado: (2023)

Refractory drug-induced systemic small-vessel vasculitis with two varied extracutaneous manifestations: a case report and review of the literature
por: Jovanovic, Mark, et al.
Publicado: (2023)

Cardiovascular outcomes with angiotensin II receptor blockers: clinical implications of recent trials
por: Baumhäkel, Magnus, et al.
Publicado: (2011)

Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk
por: Farsang, Csaba
Publicado: (2011)

Angiotensin receptor blockers for prevention of cardiovascular disease: where does the evidence stand?
por: Fuchs, Flávio Danni, et al.
Publicado: (2015)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
por: Lee, Hyun Woong
Publicado: (2014)

Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers
por: Schmidt, André C, et al.
Publicado: (2008)

The Effect of K(ATP) Channel Blocker Glibenclamide on CGRP-Induced Headache and Hemodynamic in Healthy Volunteers
por: Coskun, Hande, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cbgudhskdl9h5e7enqcctqk3pd